Plain-English translation of NCT03685721 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how genetic differences in a gene called PKLR affect the way red blood cells work in people with sickle cell disease. By comparing blood samples from people with sickle cell disease, people who carry the sickle cell trait, and healthy controls, scientists hope to understand why some people have more severe symptoms than others. This research could eventually help doctors predict who is at higher risk and develop better treatments.
Sickle cell disease happens when red blood cells become stiff and sticky, which can be influenced by levels of certain molecules inside the cells. A gene called PKLR controls an important enzyme that affects these molecules, but we don't yet understand how different genetic variations in this gene influence the severity of sickle cell disease. This study aims to fill that gap so doctors can better understand and treat the disease.
You likely qualify if…
You likely don't qualify if…
Your participation will involve one or more visits where researchers will collect a blood sample from you. The study team will ask you questions about your health history and may review your medical records. The blood sample will be tested to measure enzyme activity and genetic variations. The exact number of visits and timeline will be explained during your initial consent conversation with the study team.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States